Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 40 articles:
HTML format
Text format



Single Articles


    September 2017
  1. NOVAKOVA E, Heijkoop ST, Quint S, Zolnay AG, et al
    What is the optimal number of library plans in ART for locally advanced cervical cancer?
    Radiother Oncol. 2017 Sep 19. pii: S0167-8140(17)32557.
    PubMed     Text format     Abstract available


    May 2017
  2. DEL CAMPO ER, Rivera S, Martinez-Paredes M, Hupe P, et al
    Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30372.
    PubMed     Text format     Abstract available


  3. LI N, Noticewala SS, Williamson CW, Shen H, et al
    Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
    Radiother Oncol. 2017;123:325-330.
    PubMed     Text format     Abstract available


    April 2017
  4. DE BOER P, Jurgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, et al
    Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.
    Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30145.
    PubMed     Text format     Abstract available


  5. ANDREYCHENKO A, Kroon PS, Maspero M, Jurgenliemk-Schulz I, et al
    The feasibility of semi-automatically generated red bone marrow segmentations based on MR-only for patients with gynecologic cancer.
    Radiother Oncol. 2017;123:164-168.
    PubMed     Text format     Abstract available


    March 2017
  6. VAN HEERDEN LE, Houweling AC, Koedooder K, van Kesteren Z, et al
    Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
    Radiother Oncol. 2017 Mar 31. pii: S0167-8140(17)30111.
    PubMed     Text format     Abstract available


  7. MENDEZ LC, Weiss Y, D'Souza D, Ravi A, et al
    Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30101.
    PubMed     Text format     Abstract available


    February 2017
  8. YAMAZAKI H, Nakamura S, Suzuki G, Yoshida K, et al
    Comment on "Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer" Kari Tanderup et al.
    Radiother Oncol. 2017 Feb 22. pii: S0167-8140(17)30067.
    PubMed     Text format    


  9. RAMLOV A, Assenholt MS, Jensen MF, Gronborg C, et al
    Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer.
    Radiother Oncol. 2017 Feb 9. pii: S0167-8140(17)30040.
    PubMed     Text format     Abstract available


    January 2017
  10. SHACK L, Lu S, Weeks LA, Craighead P, et al
    Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
    Radiother Oncol. 2017;122:152-158.
    PubMed     Text format     Abstract available


    November 2016
  11. EMINOWICZ G, Rompokos V, Stacey C, Hall L, et al
    Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
    Radiother Oncol. 2016 Nov 16. pii: S0167-8140(16)34365.
    PubMed     Text format     Abstract available


    August 2016
  12. LESEUR J, Roman-Jimenez G, Devillers A, Ospina-Arango JD, et al
    Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.
    Radiother Oncol. 2016 Aug 25. pii: S0167-8140(16)31249.
    PubMed     Text format     Abstract available


  13. HAN K, Croke J, Foltz W, Metser U, et al
    A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
    Radiother Oncol. 2016 Aug 12. pii: S0167-8140(16)31234.
    PubMed     Text format     Abstract available


  14. MAZERON R, Gouy S, Chargari C, Rivin Del Campo E, et al
    Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
    Radiother Oncol. 2016 Aug 2. pii: S0167-8140(16)31202.
    PubMed     Text format     Abstract available


    July 2016
  15. JASTANIYAH N, Yoshida K, Tanderup K, Lindegaard JC, et al
    A volumetric analysis of GTVD and CTVHR as defined by the GEC ESTRO recommendations in FIGO stage IIB and IIIB cervical cancer patients treated with IGABT in a prospective multicentric trial (EMBRACE).
    Radiother Oncol. 2016 Jul 21. pii: S0167-8140(16)31158.
    PubMed     Text format     Abstract available


  16. SOLIMAN AS, Elzibak A, Easton H, Kim JY, et al
    Quantitative MRI assessment of a novel direction modulated brachytherapy tandem applicator for cervical cancer at 1.5T.
    Radiother Oncol. 2016 Jul 18. pii: S0167-8140(16)31198.
    PubMed     Text format     Abstract available


  17. MAZERON R, Fokdal LU, Kirchheiner K, Georg P, et al
    Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
    Radiother Oncol. 2016 Jul 7. pii: S0167-8140(16)31154.
    PubMed     Text format     Abstract available


    June 2016
  18. TANDERUP K, Fokdal LU, Sturdza A, Haie-Meder C, et al
    Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Radiother Oncol. 2016 Jun 24. pii: S0167-8140(16)31117.
    PubMed     Text format     Abstract available


  19. MOHAMED S, Lindegaard JC, de Leeuw AA, Jurgenliemk-Schulz I, et al
    Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2016 Jun 3. pii: S0167-8140(16)31123.
    PubMed     Text format     Abstract available


    May 2016
  20. WESTERVELD H, de Leeuw A, Kirchheiner K, Dankulchai P, et al
    Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Radiother Oncol. 2016 May 26. pii: S0167-8140(16)31090.
    PubMed     Text format     Abstract available


  21. EMINOWICZ G, Rompokos V, Stacey C, McCormack M, et al
    The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy.
    Radiother Oncol. 2016 May 6. pii: S0167-8140(16)31074.
    PubMed     Text format     Abstract available


  22. RIBEIRO I, Janssen H, De Brabandere M, Nulens A, et al
    Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Radiother Oncol. 2016 May 2. pii: S0167-8140(16)31050.
    PubMed     Text format     Abstract available


    April 2016
  23. STURDZA A, Potter R, Fokdal LU, Haie-Meder C, et al
    Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
    Radiother Oncol. 2016 Apr 29. pii: S0167-8140(16)31018.
    PubMed     Text format     Abstract available


  24. FOKDAL L, Sturdza A, Mazeron R, Haie-Meder C, et al
    Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: Analysis from the retroEMBRACE study.
    Radiother Oncol. 2016 Apr 21. pii: S0167-8140(16)31027.
    PubMed     Text format     Abstract available


    February 2016
  25. LUTGENS LC, Koper PC, Jobsen JJ, van der Steen-Banasik EM, et al
    Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.
    Radiother Oncol. 2016 Feb 17. pii: S0167-8140(16)00068.
    PubMed     Text format     Abstract available


  26. PARK JJ, Kim CK, Park BK
    Prognostic value of diffusion-weighted magnetic resonance imaging and F-fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in uterine cervical cancer.
    Radiother Oncol. 2016 Feb 15. pii: S0167-8140(16)00072.
    PubMed     Text format     Abstract available


    January 2016
  27. KIRCHHEINER K, Nout RA, Lindegaard JC, Haie-Meder C, et al
    Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Radiother Oncol. 2016 Jan 9. pii: S0167-8140(16)00002.
    PubMed     Text format     Abstract available


  28. WYSS JC, Carmona R, Karunamuni RA, Pritz J, et al
    [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.
    Radiother Oncol. 2016;118:72-8.
    PubMed     Text format     Abstract available


    December 2015
  29. LINDEGAARD JC, Madsen ML, Traberg A, Meisner B, et al
    Individualised 3D printed vaginal template for MRI guided brachytherapy in locally advanced cervical cancer.
    Radiother Oncol. 2015 Dec 29. pii: S0167-8140(15)00672.
    PubMed     Text format     Abstract available


    September 2015
  30. HEIJKOOP ST, Langerak TR, Quint S, Mens JW, et al
    Quantification of intra-fraction changes during radiotherapy of cervical cancer assessed with pre- and post-fraction Cone Beam CT scans.
    Radiother Oncol. 2015 Sep 22. pii: S0167-8140(15)00476.
    PubMed     Text format     Abstract available


  31. GLADWISH AP, Han K, Foltz WD
    Variation in apparent diffusion coefficient measurements among women with locally advanced cervical cancer.
    Radiother Oncol. 2015 Sep 13. pii: S0167-8140(15)00468.
    PubMed     Text format     Abstract available


    August 2015
  32. KIRISITS C, Federico M, Nkiwane K, Fidarova E, et al
    Quality assurance in MR image guided adaptive brachytherapy for cervical cancer: Final results of the EMBRACE study dummy run.
    Radiother Oncol. 2015 Aug 24. pii: S0167-8140(15)00407.
    PubMed     Text format     Abstract available


  33. KOBAYASHI K, Murakami N, Wakita A, Nakamura S, et al
    Dosimetric variations due to interfraction organ deformation in cervical cancer brachytherapy.
    Radiother Oncol. 2015 Aug 24. pii: S0167-8140(15)00442.
    PubMed     Text format     Abstract available


  34. CHAI Y, Wang J, Wang T, Yang Y, et al
    Application of H NMR spectroscopy-based metabonomics to feces of cervical cancer patients with radiation-induced acute intestinal symptoms.
    Radiother Oncol. 2015 Aug 12. pii: S0167-8140(15)00397.
    PubMed     Text format     Abstract available


    July 2015
  35. MAZERON R, Maroun P, Castelnau-Marchand P, Dumas I, et al
    Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
    Radiother Oncol. 2015 Jul 8. pii: S0167-8140(15)00324.
    PubMed     Text format     Abstract available


    May 2015
  36. LUND KV, Simonsen TG, Hompland T, Kristensen GB, et al
    Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
    Radiother Oncol. 2015 May 18. pii: S0167-8140(15)00210.
    PubMed     Text format     Abstract available


  37. DINGES E, Felderman N, McGuire S, Gross B, et al
    Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.
    Radiother Oncol. 2015 May 13. pii: S0167-8140(15)00214.
    PubMed     Text format     Abstract available


  38. TEO BK, Bonner Millar LP, Ding X, Lin LL, et al
    Assessment of cumulative external beam and intracavitary brachytherapy organ doses in gynecologic cancers using deformable dose summation.
    Radiother Oncol. 2015;115:195-202.
    PubMed     Text format     Abstract available


    February 2015
  39. PALMER AL, Diez P, Gandon L, Wynn-Jones A, et al
    A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
    Radiother Oncol. 2015;114:264-71.
    PubMed     Text format     Abstract available


    December 2014
  40. ARNESEN MR, Bruheim K, Malinen E, Hellebust TP, et al
    Spatial dosimetric sensitivity of contouring uncertainties in gynecological 3D-based brachytherapy.
    Radiother Oncol. 2014;113:414-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: